CTKB Tin tức Forex

Cytek Biosciences Board Approves Share Repurchase Of Up To $50 Mln

Cytek Biosciences Board Approves Share Repurchase Of Up To $50 Mln

Cell analysis solutions company Cytek Biosciences, Inc. (CTKB) announced Thursday that its Board of Directors has approved the repurchase of up to an aggregate of $50 million of its common stock, subject to compliance with applicable law.
RTTNews | 154 ngày trước